Civil society petition in SC for compulsory licence for vaccine, key Covid drugs
SECTIONS
Share
Synopsis
“Covid-19 is a public health emergency and the government is obligated to issue an order of government authorisation under Section 100 or a compulsory licence for non-commercial public use under Section 92(1) of the Patents Act to respond and ensure continued access to the vaccines,” it said in the petition in which the government is the respondent.
Agencies
There is a shortage of Remdesivir, antiviral Favipiravir and immunosuppressant Tocilizumab in India which reported a record 3.86 lakh Covid-19 cases
Civil society organisation Jan Swasthya Abhiyan (Mumbai) has filed a petition in the Supreme Court seeking direction to the Centre to issue compulsory licenses for a patent covering the drugs Remdesivir, Tocilizumab and Favipiravir, which are critical in the treatment of Covid-19 and to “rapidly upscale production”.
Writ petition filed to issue CL for Covid drugs, regulate vaccine prices
SECTIONS
Share
Synopsis
Non-governmental organisation Jan Swasthya Abhiyan (JSA) filed a writ petition in the Supreme Court, seeking a direction to the Union government to issue compulsory licences (CLs) for key Covid-19 drugs such as remdesivir, tocilizumab and favipiravir.
Agencies
Non-governmental organisation Jan Swasthya Abhiyan (JSA) filed a writ petition in the Supreme Court, seeking a direction to the Union government to issue compulsory licences (CLs) for key Covid-19 drugs such as remdesivir, tocilizumab and favipiravir. A CL will allow companies with capabilities to manufacture these drugs.
The petitioner made the health ministry, the Drugs Controller General of India, National Pharma Pricing Authority and Department for Promotion of Industry and Internal Trade, among others, party to the matter. Another petition appealed to the court to intervene in releasing the technical know-how of vaccine
Call for compulsory licence to address supply shortages
April 29, 2021
FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech s COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi//File Photo/File Photo - REUTERS
Chennai: A medic prepares to administer a dose of COVID-19 vaccine at the Government Omandurar Medical College and Hospital, in Chennai, Wednesday, April 28, 2021. (PTI Photo/R Senthil Kumar)(PTI04 28 2021 000095B) - PTI
1/2
FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech s COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi//File Photo/File Photo - REUTERS
Help Save People s World
The economic crisis has hit People s World hard. We need the support of all our friends and readers to continue publishing.
Government failure and healthcare privatization at root of India’s COVID crisis April 26, 2021 10:54 AM CDT By Vijay Prashad
A COVID-19 patient receives oxygen inside a car provided by a Gurdwara, a Sikh house of worship, in New Delhi, India, Saturday, April 24, 2021. India s oxygen shortage has become so dire that this gurdwara began offering free breathing sessions with shared tanks to patients waiting for a hospital bed. They arrive in their cars, on foot, or in three-wheeled taxis, desperate for a mask and tube attached to the precious oxygen tanks. | Altaf Qadri / AP
Covid-19 threatens to overwhelm India newzealandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newzealandstar.com Daily Mail and Mail on Sunday newspapers.